Abstract
Diabetes mellitus, an epidemic metabolic disorders characterized by high blood glucose level associated with various macrovascular and microvascular complications, is one of the main causes of human suffering across the globe. Researchers around the world mainly focused on insulin, insulin analogues, oral hypoglycemic agents and various other complementary and alternate medicines to control the blood glucose levels in diabetes. The present review summarizes the disorders associated with elevation of blood glucose level, biochemical & endocrinological aspects and the current strategies to control. The emphasis has been laid in particular on the new potential biological targets and the possible treatment as well as the current ongoing research status on new generation hypoglycemic agents.
Keywords: Diabetes, insulin, carbohydrate metabolism, sulfonylurea, thiazolidindione, carbohydrate, lipids, lipoprotein, hyperglycemia, nephropathy, retinopathy, neuropathy, T1DM, T2DM, GDM, Cystic Fibrosis, Cushing's syndrome, MHC, TH, NK, CD8, CD4, Genetic Factors, Down's syndrome, fibrinolysis, free fatty acids, glucose, Lipid Metabolism, ketone bodies, VLDL, Glucagon, Catecholamines, Growth Hormone, Glucocorticoids, DNA, Cytokines, NOS, KATP, SUR, ATP, Biguanides, Meglitinide Analogues, Thiazolidindiones, Ocimum santum, antioxidant activity, Allicin, Leucodelphinidine, Charantin, Bumelia sartorum, glycogenolysis, PPAR, GLP-1, LA, IKK, Mifepristone, DPP IV, Amylin Analog, PTP 1B, PTPase, OBA, TC-PTP
Current Medicinal Chemistry
Title: Pharmacology and Chemistry of Diabetes mellitus and Antidiabetic Drugs: A Critical Review
Volume: 17 Issue: 35
Author(s): Ganesh R. Kokil, Prarthana V. Rewatkar, Arunima Verma, Suresh Thareja and Suresh R. Naik
Affiliation:
Keywords: Diabetes, insulin, carbohydrate metabolism, sulfonylurea, thiazolidindione, carbohydrate, lipids, lipoprotein, hyperglycemia, nephropathy, retinopathy, neuropathy, T1DM, T2DM, GDM, Cystic Fibrosis, Cushing's syndrome, MHC, TH, NK, CD8, CD4, Genetic Factors, Down's syndrome, fibrinolysis, free fatty acids, glucose, Lipid Metabolism, ketone bodies, VLDL, Glucagon, Catecholamines, Growth Hormone, Glucocorticoids, DNA, Cytokines, NOS, KATP, SUR, ATP, Biguanides, Meglitinide Analogues, Thiazolidindiones, Ocimum santum, antioxidant activity, Allicin, Leucodelphinidine, Charantin, Bumelia sartorum, glycogenolysis, PPAR, GLP-1, LA, IKK, Mifepristone, DPP IV, Amylin Analog, PTP 1B, PTPase, OBA, TC-PTP
Abstract: Diabetes mellitus, an epidemic metabolic disorders characterized by high blood glucose level associated with various macrovascular and microvascular complications, is one of the main causes of human suffering across the globe. Researchers around the world mainly focused on insulin, insulin analogues, oral hypoglycemic agents and various other complementary and alternate medicines to control the blood glucose levels in diabetes. The present review summarizes the disorders associated with elevation of blood glucose level, biochemical & endocrinological aspects and the current strategies to control. The emphasis has been laid in particular on the new potential biological targets and the possible treatment as well as the current ongoing research status on new generation hypoglycemic agents.
Export Options
About this article
Cite this article as:
R. Kokil Ganesh, V. Rewatkar Prarthana, Verma Arunima, Thareja Suresh and R. Naik Suresh, Pharmacology and Chemistry of Diabetes mellitus and Antidiabetic Drugs: A Critical Review, Current Medicinal Chemistry 2010; 17 (35) . https://dx.doi.org/10.2174/092986710793361225
DOI https://dx.doi.org/10.2174/092986710793361225 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Development of Glimepiride Loaded Sustained Release Microparticles Using Tubular Microreactor
Micro and Nanosystems Prevalence of Pre-Existing Risk Factors for Adverse Events Associated with Atypical Antipsychotics Among Commercially Insured and Medicaid Insured Patients Newly Initiating Atypical Antipsychotics
Current Drug Safety Calcifediol – More than the Stepchild of CKD-MBD Therapy?
Current Vascular Pharmacology Insulin Resistance the Link between T2DM and CVD: Basic Mechanisms and Clinical Implications
Current Vascular Pharmacology Adenocarcinoma of the Appendix in Elderly: Diagnostic Dilemma
New Emirates Medical Journal Structural, Biochemical and Non-Traditional Cardiovascular Risk Markers in PCOS
Current Pharmaceutical Design Reduction in Estimated Glomerular Filtration Rate (eGFR) Results in an Increased Risk of Spontaneous Hemorrhagic Transformation in Patients with Large-artery Atherosclerosis Stroke
Current Neurovascular Research Current Options in the Treatment of Mitochondrial Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Recent Advances in Obesity Pharmacotherapy
Current Clinical Pharmacology Dietary Factors Influencing Magnesium Absorption in Humans
Current Nutrition & Food Science Editorial: Liraglutide and Cardiometabolic Effects: More than Just Another Antiobesity Drug?
Current Vascular Pharmacology Risk of Bleeding Related to Antithrombotic Treatment in Cardiovascular Disease
Current Pharmaceutical Design High-density Lipoprotein, Vascular Risk, Cancer and Infection: A Case of Quantity and Quality?
Current Medicinal Chemistry Modulation of Proinflammatory Bacteria- and Lipid-Coupled Intracellular Signaling Pathways in a Transwell Triple Co-Culture Model by Commensal Bifidobacterium Animalis R101-8
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Role of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Different Disease States: Recent Updates
Current Medicinal Chemistry The Anti-Atherogenic Effects of Thiazolidinediones
Current Diabetes Reviews Coffee to Reduce Risk of Type 2 Diabetes? : A Systematic Review
Current Diabetes Reviews Therapeutic Potential of the Mammalian Pyruvate Dehydrogenase Kinases in the Prevention of Hyperglycaemia
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Therapeutic Agents for COVID-19: an Overview
Current Drug Therapy Validation of TZD Scaffold as Potential ARIs: Pharmacophore Modeling, Atom-based 3D QSAR and Docking Studies
Combinatorial Chemistry & High Throughput Screening